trastuzumab pamirtecan
Generic: Trastuzumab Pamirtecan
trastuzumab pamirtecan: 1 clinical trial tracked.
trastuzumab pamirtecan evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about trastuzumab pamirtecan, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase I/II, Multi-site, Open-label, Two-part Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of BNT323 in Combination With BNT327 in Participants With Advanced Breast Cancer
Primary endpoint: Part 1 - Occurrence of dose limiting toxicities (DLTs)
InterventionalRandomizedopen380 targetStarted 2025-04Completion 2029-0850 sites · Australia, Canada, China, France…BioNTech SE